Your browser doesn't support javascript.
loading
Nevirapine-associated rash in a Jamaican child with HIV/AIDS
Steel-Duncan, J. C; Pierre, R; Gabay, L; Christie, C. D.
Affiliation
  • Steel-Duncan, J. C; University of the West Indies. Kingston. JM
  • Pierre, R; University of the West Indies. Kingston. JM
  • Gabay, L; University of the West Indies. Kingston. JM
  • Christie, C. D; University of the West Indies. Kingston. JM
West Indian med. j ; 53(5): 356-358, Oct. 2004.
Article in En | LILACS | ID: lil-410231
Responsible library: BR1.1
RESUMO
Nevirapine is one of the first line antiretroviral agents used in the treatment of HIV/AIDS as well as for prophylaxis against mother-to-child transmission of HIV As antiretroviral medication becomes more available it is important for physicians to recognize the major clinical toxicities of these medications. We report a HIV-infected infant who developed a rash with systemic symptoms in association with nevirapine administration
Subject(s)
Search on Google
Index: LILACS Main subject: HIV Infections / Anti-HIV Agents / Nevirapine / Exanthema Type of study: Risk_factors_studies Limits: Humans / Infant / Male Country/Region as subject: Caribe ingles / Jamaica Language: En Journal: West Indian med. j Journal subject: MEDICINA Year: 2004 Type: Article
Search on Google
Index: LILACS Main subject: HIV Infections / Anti-HIV Agents / Nevirapine / Exanthema Type of study: Risk_factors_studies Limits: Humans / Infant / Male Country/Region as subject: Caribe ingles / Jamaica Language: En Journal: West Indian med. j Journal subject: MEDICINA Year: 2004 Type: Article